Document is current
Any future updates will be listed below
-
Authors
Campbell, Iain H. https://orcid.org/0000-0001-8756-1326
Frye, Mark A. https://orcid.org/0000-0001-6997-4215
Campbell, Harry
- License Information
-
More Information
Article History
Received: 14 November 2024
Revised: 19 June 2025
Accepted: 9 July 2025
First Online: 19 July 2025
Competing interests
: Dr. Iain H. Campbell has a diagnosis of Bipolar Disorder Type 2 and follows a seizure-control type Ketogenic Diet. Dr. Campbell’s fellowship is funded by the Baszucki Brain Research Fund. Dr. Campbell has received consulting fees from Mayo Clinic and Abbott Lingo. Dr Harry Campbell has received grant funding from the UK National Institute of Health Research, Medical Research Council, the EU and the Baszucki Group. Dr. Mark A. Frye has received grant support research funding from Assurex Health, Baszucki Group, Breakthrough Discoveries for Thriving with Bipolar Disorder (BD2), Mayo Foundation, provided continuing medical lectures sponsored by Carnot Laboratories and American Physician Institute and has Financial Interest / Stock ownership / Royalties in Chymia LLC.
